Sale!

Goodpasture’s Syndrome Panel Test

740 د.إ

-10%

Goodpasture’s Syndrome Panel Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect the presence of Goodpasture’s Syndrome, an autoimmune disease that primarily affects the kidneys and lungs. This condition leads to the production of antibodies that attack the body’s own tissues, particularly the basement membranes in the lungs and kidneys, resulting in bleeding in the lungs and inflammation in the kidneys, which can lead to serious health complications if not diagnosed and treated promptly.

The test specifically looks for anti-glomerular basement membrane (anti-GBM) antibodies in the blood, which are indicative of Goodpasture’s Syndrome. It is a critical tool for physicians to confirm the diagnosis, allowing for timely and appropriate treatment to prevent further organ damage.

At DNA Labs UAE, the Goodpasture’s Syndrome Panel Test is offered at a cost of 740 AED. The test is conducted with high precision and accuracy, ensuring reliable results for patients. DNA Labs UAE is equipped with state-of-the-art facilities and staffed by experienced professionals, guaranteeing quality service and care for those undergoing testing. This test is essential for individuals exhibiting symptoms of the syndrome or those with a high risk of developing the condition, facilitating early intervention and management of the disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GOODPASTURE’S SYNDROME PANEL Test

Test Name: GOODPASTURE’S SYNDROME PANEL

Test Components:

  • Glomerular Basement Membrane Antibody
  • ANCA-PR3 / c-ANCA

Price: 740.0 AED

Sample Condition: 3 ml (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery: Sample Mon / Wed by 9 am; Report Next day

Method: Enzyme Immunoassay, IFA

Test Type: Disorders of Kidney, Disorders of Lung

Doctor: Nephrologist, Chest Physician

Test Department: IMMUNOPATHOLOGY

Pre Test Information: No special preparation required

Test Details

The GOODPASTURE’S SYNDROME PANEL test is a diagnostic test used to detect the presence of autoantibodies associated with Goodpasture’s syndrome. Goodpasture’s syndrome is a rare autoimmune disorder that primarily affects the kidneys and lungs.

The panel typically includes the following tests:

  1. Anti-glomerular basement membrane (anti-GBM) antibodies: This test detects the presence of autoantibodies that target the glomerular basement membrane, which is a key feature of Goodpasture’s syndrome.
  2. Anti-neutrophil cytoplasmic antibodies (ANCA): This test is performed to rule out other autoimmune disorders that may present with similar symptoms. ANCA antibodies are commonly found in other conditions such as vasculitis.
  3. Kidney function tests: Blood and urine tests are performed to assess kidney function and determine if there is any kidney damage.
  4. Chest X-ray or CT scan: These imaging tests may be performed to evaluate the lungs for any abnormalities or bleeding.

The results of the Goodpasture’s syndrome panel test can help confirm or rule out a diagnosis of Goodpasture’s syndrome and guide appropriate treatment. Treatment typically involves immunosuppressive medications and plasma exchange to remove the autoantibodies from the blood.

Test Name GOODPASTUREÆ’??S SYNDROME PANEL Test
Components *Glomerular Basement Membrane Antibody*ANCA-PR3 / c-ANCA
Price 740.0 AED
Sample Condition 3 ml (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery Sample Mon / Wed by 9 am; Report Next day
Method Enzyme Immunoassay, IFA
Test type Disorders of Kidney, Disorders of Lung
Doctor Nephrologist, Chest Physician
Test Department: IMMUNOPATHOLOGY
Pre Test Information No special preparation required
Test Details

The GOODPASTURE’S SYNDROME PANEL test is a diagnostic test used to detect the presence of autoantibodies associated with Goodpasture’s syndrome. Goodpasture’s syndrome is a rare autoimmune disorder that primarily affects the kidneys and lungs.

The panel typically includes the following tests:

1. Anti-glomerular basement membrane (anti-GBM) antibodies: This test detects the presence of autoantibodies that target the glomerular basement membrane, which is a key feature of Goodpasture’s syndrome.

2. Anti-neutrophil cytoplasmic antibodies (ANCA): This test is performed to rule out other autoimmune disorders that may present with similar symptoms. ANCA antibodies are commonly found in other conditions such as vasculitis.

3. Kidney function tests: Blood and urine tests are performed to assess kidney function and determine if there is any kidney damage.

4. Chest X-ray or CT scan: These imaging tests may be performed to evaluate the lungs for any abnormalities or bleeding.

The results of the Goodpasture’s syndrome panel test can help confirm or rule out a diagnosis of Goodpasture’s syndrome and guide appropriate treatment. Treatment typically involves immunosuppressive medications and plasma exchange to remove the autoantibodies from the blood.